iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/26578393
Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr:93:175-85.
doi: 10.1016/j.yjmcc.2015.11.005. Epub 2015 Nov 11.

Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling

Margaux A Horn  1 , Andrew W Trafford  2
Affiliations
Review

Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling

Margaux A Horn et al. J Mol Cell Cardiol. 2016 Apr.

Abstract

Cardiovascular disease is a leading cause of death worldwide and there is a pressing need for new therapeutic strategies to treat such conditions. The risk of developing cardiovascular disease increases dramatically with age, yet the majority of experimental research is executed using young animals. The cardiac extracellular matrix (ECM), consisting predominantly of fibrillar collagen, preserves myocardial integrity, provides a means of force transmission and supports myocyte geometry. Disruptions to the finely balanced control of collagen synthesis, post-synthetic deposition, post-translational modification and degradation may have detrimental effects on myocardial functionality. It is now well established that the aged heart is characterized by fibrotic remodelling, but the mechanisms responsible for this are incompletely understood. Furthermore, studies using aged animal models suggest that interstitial remodelling with disease may be age-dependent. Thus with the identification of new therapeutic strategies targeting fibrotic remodelling, it may be necessary to consider age-dependent mechanisms. In this review, we discuss remodelling of the cardiac collagen matrix as a function of age, whilst highlighting potential novel mediators of age-dependent fibrotic pathways.

Keywords: Aging; Collagen; Extracellular matrix; Fibrosis; Heart failure.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic representation of age-related alterations to the cardiac collagen matrix. Both cellular and interstitial remodelling occur as a result of aging in the myocardium. Myocyte loss occurs through apoptotic and/or necrotic pathways. This results in hypertrophy of remaining myocytes and replacement fibrosis. Perivascular and reactive fibrosis occurs by accumulation of collagen in the interstitial space. Post-translational modification of collagen, including enhanced cross-linking is also present.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Redfield M.M., Jacobsen S.J., Burnett J.C., Jr., Mahoney D.W., Bailey K.R., Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. J. Am. Med. Assoc. 2003;289:194–202. - PubMed
    1. Jugdutt B.I. Aging and heart failure: changing demographics and implications for therapy in the elderly. Heart Fail. Rev. 2010;15:401–405. - PubMed
    1. Cherubini A., Oristrell J., Pla X., Ruggiero C., Ferretti R., Diestre G. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch. Intern. Med. 2011;171:550–556. - PubMed
    1. Herrera A.P., Snipes S.A., King D.W., Torres-Vigil I., Goldberg D.S., Weinberg A.D. Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change. Am. J. Public Health. 2010;100(Suppl. 1) (S105-S12) - PMC - PubMed
    1. Konrat C., Boutron I., Trinquart L., Auleley G.R., Ricordeau P., Ravaud P. Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. PLoS One. 2012;7 - PMC - PubMed

Publication types

MeSH terms